Our result showed that rs1042489 C/T polymorphism didn't correlate with the risk of HCC, indicating this polymorphism probably had nothing to do with the stability of survivin mRNA or its translational efficiency [30]. This evidence concerns the gene BIRC5 and hepatocellular carcinoma.